134 related articles for article (PubMed ID: 29434597)
1. 92R Monoclonal Antibody Inhibits Human CCR9
Somovilla-Crespo B; Martín Monzón MT; Vela M; Corraliza-Gorjón I; Santamaria S; Garcia-Sanz JA; Kremer L
Front Immunol; 2018; 9():77. PubMed ID: 29434597
[TBL] [Abstract][Full Text] [Related]
2. Antitumor effects of a monoclonal antibody to human CCR9 in leukemia cell xenografts.
Chamorro S; Vela M; Franco-Villanueva A; Carramolino L; Gutiérrez J; Gómez L; Lozano M; Salvador B; García-Gallo M; Martínez-A C; Kremer L
MAbs; 2014; 6(4):1000-12. PubMed ID: 24870448
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic potential of an anti-CCR9 mAb evidenced in xenografts of human CCR9
Santamaria S; Delgado M; Botas M; Castellano E; Corraliza-Gorjon I; Lafuente P; Muñoz-Calleja C; Toribio ML; Kremer L; Garcia-Sanz JA
Front Immunol; 2022; 13():825635. PubMed ID: 35967322
[TBL] [Abstract][Full Text] [Related]
4. Development of Anti-Human CC Chemokine Receptor 9 Monoclonal Antibodies for Flow Cytometry.
Nanamiya R; Takei J; Asano T; Tanaka T; Sano M; Nakamura T; Yanaka M; Hosono H; Kaneko MK; Kato Y
Monoclon Antib Immunodiagn Immunother; 2021 Jun; 40(3):101-106. PubMed ID: 34161159
[TBL] [Abstract][Full Text] [Related]
5. CCR9-CCL25 interaction suppresses apoptosis of lung cancer cells by activating the PI3K/Akt pathway.
Li B; Wang Z; Zhong Y; Lan J; Li X; Lin H
Med Oncol; 2015 Mar; 32(3):66. PubMed ID: 25691296
[TBL] [Abstract][Full Text] [Related]
6. Role of beta7 integrin and the chemokine/chemokine receptor pair CCL25/CCR9 in modeled TNF-dependent Crohn's disease.
Apostolaki M; Manoloukos M; Roulis M; Wurbel MA; Müller W; Papadakis KA; Kontoyiannis DL; Malissen B; Kollias G
Gastroenterology; 2008 Jun; 134(7):2025-35. PubMed ID: 18439426
[TBL] [Abstract][Full Text] [Related]
7. CCR9 mediates PI3K/AKT-dependent antiapoptotic signals in prostate cancer cells and inhibition of CCR9-CCL25 interaction enhances the cytotoxic effects of etoposide.
Sharma PK; Singh R; Novakovic KR; Eaton JW; Grizzle WE; Singh S
Int J Cancer; 2010 Nov; 127(9):2020-30. PubMed ID: 20127861
[TBL] [Abstract][Full Text] [Related]
8. MLN3126, an antagonist of the chemokine receptor CCR9, ameliorates inflammation in a T cell mediated mouse colitis model.
Igaki K; Komoike Y; Nakamura Y; Watanabe T; Yamasaki M; Fleming P; Yang L; Soler D; Fedyk E; Tsuchimori N
Int Immunopharmacol; 2018 Jul; 60():160-169. PubMed ID: 29730559
[TBL] [Abstract][Full Text] [Related]
9. CCR9+ T cells contribute to the resolution of the inflammatory response in a mouse model of intestinal amoebiasis.
Rojas-López AE; Soldevila G; Meza-Pérez S; Dupont G; Ostoa-Saloma P; Wurbel MA; Ventura-Juárez J; Flores-Romo L; García-Zepeda EA
Immunobiology; 2012 Aug; 217(8):795-807. PubMed ID: 22633147
[TBL] [Abstract][Full Text] [Related]
10. CCR9 Antagonists in the Treatment of Ulcerative Colitis.
Bekker P; Ebsworth K; Walters MJ; Berahovich RD; Ertl LS; Charvat TT; Punna S; Powers JP; Campbell JJ; Sullivan TJ; Jaen JC; Schall TJ
Mediators Inflamm; 2015; 2015():628340. PubMed ID: 26457007
[TBL] [Abstract][Full Text] [Related]
11. Characterization of CCR9 expression and thymus-expressed chemokine responsiveness of the murine thymus, spleen and mesenteric lymph node.
Lee HS; Kim HR; Lee EH; Jang MH; Kim SB; Park JW; Seoh JY; Jung YJ
Immunobiology; 2012 Apr; 217(4):402-11. PubMed ID: 22196895
[TBL] [Abstract][Full Text] [Related]
12. Antitumor activity of an anti-CD98 antibody.
Hayes GM; Chinn L; Cantor JM; Cairns B; Levashova Z; Tran H; Velilla T; Duey D; Lippincott J; Zachwieja J; Ginsberg MH; H van der Horst E
Int J Cancer; 2015 Aug; 137(3):710-20. PubMed ID: 25556716
[TBL] [Abstract][Full Text] [Related]
13. Development of a Sensitive Anti-Human CCR9 Monoclonal Antibody (C
Tanaka T; Suzuki H; Isoda Y; Asano T; Nakamura T; Yanaka M; Handa S; Takahashi N; Okuno S; Yoshikawa T; Li G; Nanamiya R; Goto N; Tateyama N; Okada Y; Kobayashi H; Kaneko MK; Kato Y
Monoclon Antib Immunodiagn Immunother; 2022 Dec; 41(6):303-310. PubMed ID: 36383113
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of antitumor activity in mice for anti-epidermal growth factor receptor monoclonal antibodies with different isotypes.
Masui H; Moroyama T; Mendelsohn J
Cancer Res; 1986 Nov; 46(11):5592-8. PubMed ID: 3756906
[TBL] [Abstract][Full Text] [Related]
15. LINC00853 restrains T cell acute lymphoblastic leukemia invasion and infiltration by regulating CCR9/CCL25.
Li J; Muhammad J; Xie T; Sun J; Lei Y; Wei Z; Pan S; Qin H; Shao L; Jiang D; Zhang Q
Mol Immunol; 2021 Dec; 140():267-275. PubMed ID: 34808497
[TBL] [Abstract][Full Text] [Related]
16. The human agonistic CD40 antibody ADC-1013 eradicates bladder tumors and generates T-cell-dependent tumor immunity.
Mangsbo SM; Broos S; Fletcher E; Veitonmäki N; Furebring C; Dahlén E; Norlén P; Lindstedt M; Tötterman TH; Ellmark P
Clin Cancer Res; 2015 Mar; 21(5):1115-26. PubMed ID: 25316820
[TBL] [Abstract][Full Text] [Related]
17. Anti-CCR7 monoclonal antibodies as a novel tool for the treatment of chronic lymphocyte leukemia.
Alfonso-Pérez M; López-Giral S; Quintana NE; Loscertales J; Martín-Jiménez P; Muñoz C
J Leukoc Biol; 2006 Jun; 79(6):1157-65. PubMed ID: 16603585
[TBL] [Abstract][Full Text] [Related]
18. Chemokine (C-C motif) ligand 25 expressed by trophoblast cells and leukocytes bearing its receptor Ccr9: An alliance during embryo implantation?
Weingrill RB; Hoshida MS; Martinhago CD; Correa-Silva S; Cardoso E; Palmeira P; Marinho CRF; Bevilacqua E
Am J Reprod Immunol; 2018 Jan; 79(1):. PubMed ID: 29154408
[TBL] [Abstract][Full Text] [Related]
19. IL-2Ralpha-Directed monoclonal antibodies provide effective therapy in a murine model of adult T-cell leukemia by a mechanism other than blockade of IL-2/IL-2Ralpha interaction.
Phillips KE; Herring B; Wilson LA; Rickford MS; Zhang M; Goldman CK; Tso JY; Waldmann TA
Cancer Res; 2000 Dec; 60(24):6977-84. PubMed ID: 11156399
[TBL] [Abstract][Full Text] [Related]
20. CCR9 Is a Key Regulator of Early Phases of Allergic Airway Inflammation.
López-Pacheco C; Soldevila G; Du Pont G; Hernández-Pando R; García-Zepeda EA
Mediators Inflamm; 2016; 2016():3635809. PubMed ID: 27795621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
